May 31, 2021 Environ, Ag./Food & Bev Licensing, IP, and Legal M&A, Partnerships

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

MELBOURNE, Australia–(BUSINESS WIRE)–Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in laboratory services and reproductive science, today announced the launch of VeriSeq™ NIPT Solution v2 in Thailand, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal... Read more

May 28, 2021 Licensing, IP, and Legal M&A, Partnerships

GE Healthcare, NSIA and IFC Partner to Strengthen Medical Equipment Financing Support Across Africa

Johannesburg, South Africa, May 28, 2021—To help small businesses in Africa’s health sector strengthen their response to COVID-19 and other pressing healthcare challenges, GE Healthcare and NSIA Banque Côte d’Ivoire have partnered with IFC’s Africa Medical Equipment Facility to support healthcare providers in Cameroon, Côte d’Ivoire, Kenya, Rwanda, Senegal, Tanzania, and Uganda access essential medical... Read more

May 20, 2021 Licensing, IP, and Legal Liq. Handling & Robotics

Brooks to Participate in the Jefferies Virtual Healthcare Conference

CHELMSFORD, Mass., May 20, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 which includes a webcast beginning at 9:00 a.m. ET.  The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events.  A replay of the... Read more

May 12, 2021 Lab Top-10 Licensing, IP, and Legal M&A, Partnerships PAI Top-10

PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing WALTHAM, Mass.–(BUSINESS WIRE)–May 12, 2021– PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close... Read more

May 11, 2021 Licensing, IP, and Legal Liq. Handling & Robotics

Brooks to Participate in the 16th Annual Needham Virtual Technology & Media Conference

Brooks to Participate in the 16th Annual Needham Virtual Technology & Media Conference CHELMSFORD, Mass., May 11, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the 16th  Annual Needham Virtual Technology & Media Conference on Thursday, May 20, 2021 which includes a webcast beginning at 11:00 a.m. ET. ... Read more

May 11, 2021 Licensing, IP, and Legal Life Science Tools

Court of Appeals for the Federal Circuit, US, upholds jury decision to invalidate certain PacBio patents

Tue 11th May 2021 Today the Court of Appeals for the Federal Circuit issued a unanimous Precedential Opinion and Judgment affirming the jury’s March 2020 verdict in the PacBio v. Oxford Nanopore case, that invalidated a number of PacBio patents.  This has been a long running dispute in which Oxford Nanopore has repeatedly prevailed.  In... Read more

April 28, 2021 Acad, Gov/Utilities Environ, Ag./Food & Bev Licensing, IP, and Legal M&A, Partnerships

Xylem, Esri Partnership Pairs Global Leaders In Water Technology And GIS To Help Utilities Worldwide Streamline Data And Insight

Xylem Becomes Platinum Esri Partner, Will Create Joint Solutions, Collaborate On Marketing Water Operators To Benefit From Better Network Visibility, Optimized Infrastructure, Lower Costs RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 28, 2021– Xylem (NYSE:XYL), a leading water technology company dedicated to solving the world’s greatest water challenges, has forged a partnership with Esri, the global leader in... Read more

April 28, 2021 Acad, Gov/Utilities Bio/Pharma/CRO Lab Top-10 Licensing, IP, and Legal

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society WALTHAM, Mass. (April 28, 2021) — Thermo Fisher Scientific Inc. has made a donation to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval... Read more

April 27, 2021 Acad, Gov/Utilities Licensing, IP, and Legal

US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for PD-L1-positive, metastatic triple-negative breast cancer

Basel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 7 to 2 in favour of maintaining accelerated approval of Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally... Read more